368 related articles for article (PubMed ID: 30383406)
1.
Kumar R; Mittal BR; Bhattacharya A; Singh H; Bal A; Prakash G; Singh N
AJR Am J Roentgenol; 2019 Jan; 212(1):W10-W18. PubMed ID: 30383406
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic performance of real-time robotic arm-assisted
Kumar R; Mittal BR; Bhattacharya A; Singh H; Bal A; Vadi SK; Sood A; Prakash G; Singh H; Sharma A
Eur J Nucl Med Mol Imaging; 2019 Apr; 46(4):838-847. PubMed ID: 30167803
[TBL] [Abstract][Full Text] [Related]
3. Real-time intraprocedural
Radhakrishnan RK; Mittal BR; Gorla AKR; Basher RK; Sood A; Bal A; Kalra N; Khandelwal N; Singh N; Behera D
Br J Radiol; 2017 Dec; 90(1080):20170258. PubMed ID: 28937268
[TBL] [Abstract][Full Text] [Related]
4. Positron emission tomography/computed tomography guided percutaneous biopsies of Ga-68 avid lesions using an automated robotic arm.
Kumar R; Mittal BR; Bhattacharya A; Vadi SK; Singh H; Bal A; Shukla J; Singh H; Sharma V; Sood A; Singh SK
Diagn Interv Imaging; 2020 Mar; 101(3):157-167. PubMed ID: 31722844
[TBL] [Abstract][Full Text] [Related]
5. Robotic-assisted computed tomography-guided 18F-FDG PET/computed tomography-directed biopsy for diagnosis of intra thoracic lesions: An experience from a tertiary care centre in North India.
Nath A; Prashanth A; Lal H; Kumar S; Barai S; Gambhir S
Nucl Med Commun; 2020 Mar; 41(3):246-251. PubMed ID: 31939902
[TBL] [Abstract][Full Text] [Related]
6. PET/CT-guided percutaneous biopsy of FDG-avid metastatic bone lesions in patients with advanced lung cancer: a safe and effective technique.
Guo W; Hao B; Chen HJ; Zhao L; Luo ZM; Wu H; Sun L
Eur J Nucl Med Mol Imaging; 2017 Jan; 44(1):25-32. PubMed ID: 27444682
[TBL] [Abstract][Full Text] [Related]
7. Post-therapy lesions in patients with non-Hodgkin's lymphoma characterized by 18F-FDG PET/CT-guided biopsy using automated robotic biopsy arm.
Radhakrishnan RK; Mittal BR; Basher RK; Prakash G; Malhotra P; Kalra N; Das A
Nucl Med Commun; 2018 Jan; 39(1):74-82. PubMed ID: 29189443
[TBL] [Abstract][Full Text] [Related]
8. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
9. PET/CT-guided versus CT-guided percutaneous core biopsies in the diagnosis of bone tumors and tumor-like lesions: which is the better choice?
Wu MH; Xiao LF; Liu HW; Yang ZQ; Liang XX; Chen Y; Lei J; Deng ZM
Cancer Imaging; 2019 Oct; 19(1):69. PubMed ID: 31665093
[TBL] [Abstract][Full Text] [Related]
10. Is it sufficient to evaluate bone marrow involvement in newly diagnosed lymphomas using
Hao B; Zhao L; Luo NN; Ruan D; Pang YZ; Guo W; Fu H; Guo XY; Luo ZM; Wu J; Chen HJ; Wu H; Sun L
BMC Cancer; 2018 Nov; 18(1):1192. PubMed ID: 30497426
[TBL] [Abstract][Full Text] [Related]
11. PET/CT-Guided Tissue Sampling in Patients With a Failed or Inconclusive CT-Guided Procedure: Outcomes and Contributing Factors.
Kumar R; Sharma A; Thulkar S; Iyer VK; Sharma A
Clin Nucl Med; 2020 Aug; 45(8):581-587. PubMed ID: 32558712
[TBL] [Abstract][Full Text] [Related]
12. Comparison of CT and PET/CT for biopsy guidance in oncological patients.
Cerci JJ; Tabacchi E; Bogoni M; Delbeke D; Pereira CC; Cerci RJ; Krauzer C; Sakamoto DG; Fanti S; Vitola JV
Eur J Nucl Med Mol Imaging; 2017 Aug; 44(8):1269-1274. PubMed ID: 28364161
[TBL] [Abstract][Full Text] [Related]
13. Feasibility of a multimodal (18)F-FDG-directed lymph node surgical excisional biopsy approach for appropriate diagnostic tissue sampling in patients with suspected lymphoma.
Povoski SP; Hall NC; Murrey DA; Wright CL; Martin EW
BMC Cancer; 2015 May; 15():378. PubMed ID: 25953144
[TBL] [Abstract][Full Text] [Related]
14. Malignancy rate of biopsied suspicious bone lesions identified on FDG PET/CT.
Adams HJ; de Klerk JM; Heggelman BG; Dubois SV; Kwee TC
Eur J Nucl Med Mol Imaging; 2016 Jul; 43(7):1231-8. PubMed ID: 26728144
[TBL] [Abstract][Full Text] [Related]
15. In newly diagnosed diffuse large B-cell lymphoma, determination of bone marrow involvement with 18F-FDG PET/CT provides better diagnostic performance and prognostic stratification than does biopsy.
Berthet L; Cochet A; Kanoun S; Berriolo-Riedinger A; Humbert O; Toubeau M; Dygai-Cochet I; Legouge C; Casasnovas O; Brunotte F
J Nucl Med; 2013 Aug; 54(8):1244-50. PubMed ID: 23674577
[TBL] [Abstract][Full Text] [Related]
16. Minimal invasive biopsy of intraconal expansion by PET/CT/MRI image-guided navigation: a new method.
Reinbacher KE; Pau M; Wallner J; Zemann W; Klein A; Gstettner C; Aigner RM; Feichtinger M
J Craniomaxillofac Surg; 2014 Oct; 42(7):1184-9. PubMed ID: 24726395
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic value of navigation-guided core needle biopsy in deep regions of the head and neck with focal FDG uptake on
Gao Y; Wu WJ; Zheng L; Huang MW; Liu SM; Zhang JG
J Craniomaxillofac Surg; 2020 May; 48(5):508-513. PubMed ID: 32143863
[TBL] [Abstract][Full Text] [Related]
18. Real-Time Ultrasound Image Fusion with FDG-PET/CT to Perform Fused Image-Guided Fine-Needle Aspiration in Neck Nodes: Feasibility and Diagnostic Value.
de Koekkoek-Doll PK; Maas M; Vogel W; Castelijns J; Smit L; Zavrakidis I; Beets-Tan R; van den Brekel M
AJNR Am J Neuroradiol; 2021 Mar; 42(3):566-572. PubMed ID: 33509917
[TBL] [Abstract][Full Text] [Related]
19. The value of prebiopsy FDG-PET/CT in discriminating malignant from benign vertebral bone lesions in a predominantly oncologic population.
Loudini N; Glaudemans AWJM; Jutte PC; Yakar D; Kwee TC
Skeletal Radiol; 2020 Sep; 49(9):1387-1395. PubMed ID: 32253470
[TBL] [Abstract][Full Text] [Related]
20. The role of 18F-FDG PET/CT in staging and restaging primary bone lymphoma.
Liu Y
Nucl Med Commun; 2017 Apr; 38(4):319-324. PubMed ID: 28225435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
